Single-nucleotide polymorphism-based differentiation and drug resistance detection in Mycobacterium tuberculosis from isolates or directly from sputum-Reference-Cited by-同舟云学术

Single-nucleotide polymorphism-based differentiation and drug resistance detection in Mycobacterium tuberculosis from isolates or directly from sputum

Published:2005-02 Issue:2 Volume:11 Page:122-130
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Arnold C.,Westland L.,Mowat G.,Underwood A.,Magee J.,Gharbia S.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference30 articles.

1. Current medical treatment for tuberculosis;Chan;BMJ,2002

2. Tuberculosis fact sheet number 104;World Health Organization,2002

3. Molecular determinants of drug resistance in tuberculosis;Riska;Int J Tuberc,2000

4. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis;Ramaswamy;Antimicrob Agents Chemother,2003

5. The molecular basis of resistance to isoniazid, rifampin and pyrazinamide in Mycobacterium tuberculosis;Somoskovi;Respir Res,2001

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in single-nucleotide variant assay: From in vitro detection to in vivo imaging;TrAC Trends in Analytical Chemistry;2024-11

2. Learning from Classic: DNA-Based Conditional Equilibrium Constant To Regulate Affinity “On-the-Fly” for Bioassays;Analytical Chemistry;2024-09-14

3. Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: a systematic review and meta-analysis;The Lancet Infectious Diseases;2024-05

4. Simulation-Guided Rational Design of DNA Probe for Accurate Discrimination of Single-Nucleotide Variants Based on “Hill-Type” Cooperativity;Analytical Chemistry;2023-01-25

5. Pyrosequencing for diagnosis of multidrug and extensively drug-resistant tuberculosis: A systemic review and meta-analysis;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2021-08